Recently two naturally occurring compounds, rhein and naringenin, have been verified as LXRα/β and LXRα antagonists respectively and have also been shown to have hyperlipidemia lowering properties [48], [49]. The gene discussed is NR1H3; the disease is hyperlipidemia.